NEW YORK (GenomeWeb News) — Open Biosystems will sell and distribute Codon Devices’ BioFAB synthetic genetics platform in North America, Codon said Monday.  
Codon said the agreement is part of its effort to extend its BioFAB platform to a broader market. Previously, Codon offered BioFAB only to customers able to meet minimum order requirements.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.